{"id":79068,"date":"2023-11-09T12:28:00","date_gmt":"2023-11-09T15:28:00","guid":{"rendered":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/open-health-presenting-innovative-research-on-capitalizing-data-for-patient-access-at-ispor-europe\/"},"modified":"2023-11-09T12:28:00","modified_gmt":"2023-11-09T15:28:00","slug":"open-health-presenting-innovative-research-on-capitalizing-data-for-patient-access-at-ispor-europe","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/open-health-presenting-innovative-research-on-capitalizing-data-for-patient-access-at-ispor-europe\/","title":{"rendered":"OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe"},"content":{"rendered":"<p><b>Open Health<\/b><\/p>\n<p>London, Nov.  09, 2023  (GLOBE NEWSWIRE) &#8212; <br \/>London, UK  November 9, 2023 \u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HYt2T_MV3Sv6l9XLTNtIJuVK59PJhx03DojCQsobILwbc5MXtJC3iSXqFjmNiw32jr8O-jee4CS371Z99r-52B6uY0_aLOvWoKXor97LwLiQo7T1R0AmG5iyv6muZVge\" rel=\"nofollow noopener\" target=\"_blank\">OPEN Health<\/a>, a preeminent global provider of\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Z10DRAScBCJUP0q_fR2e6HRFjNrcOlCnfje2OEuX2Eo-31WsG7zuwt1it9ul2nVf9mnJVJBGwWOL4tQiNBfAYYBwDqC0nUPwmCJtZ_P_cldD8h-VQrAs0BJd9lIxEfP76dYgppkSix__Nfh0-qfo5A==\" rel=\"nofollow noopener\" target=\"_blank\">consulting<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jlBUoAoG5QLUWVlziObJ4IyT_gdLWjlNBzCsgM8tnZdekh5FT3Hmj4kgw9c2MGt7krtqVM45YipmlBJNOULt7nW64up0jHhwlNSEvoTucLiQMXgSUfFJlCNubZ0Pd6hcOt8r5cAw-TkWQDxyVXNGVxJZzpVq8yGe0HgwNsdv9Io=\" rel=\"nofollow noopener\" target=\"_blank\">HEOR and market access<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VklwVrsPaXzWl0HWklvrMrTcc3ESm2XrxcW7K-Xngi1_KcRCLfck3LanR_rgnjtd4u-DrtrCfUjUA05OxzHKOF0u1EUYJQfqNY4OA75aRFjARokr55dDhKJnOCU9iZ3svhmir6-UFLrupeDwU6mwm-vrgqNzC7zaDKGcD1tFZZE=\" rel=\"nofollow noopener\" target=\"_blank\">patient engagement<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sZZTVfYe3RRBmNmazlWISRasZ7s6rCrIUtLxfV7rBeKe9RD9Wc0hoRwj1nBwfy1XLrIe43CHX1_ziN-yvwcoOdyrcA72euGVmULxctMQWNq7OfWh9o1rVz4v4Kb5hByCTm07BsqhSF5pCXJWiZBHlLXJkP1AwdIGtoUqWgaAO6w=\" rel=\"nofollow noopener\" target=\"_blank\">scientific<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pX45oDCFkZo3PmI0FO2z-XEuM4w3tIf-WfGwHZCgA1zR0gX2j1Z-F-tuPOLueREsPZbO9cJv-z5DsnoSa6mDhLzT0IRy8qzh48QLdo-YZX_n44aETMN0md0usqp-pO2wdbaexwraxOEa0ScnAsJHjvK1RTI8kiVdnBSdpBYswCc=\" rel=\"nofollow noopener\" target=\"_blank\">creative communications<\/a>\u00a0services, will be presenting innovative research at the upcoming ISPOR Europe conference in Copenhagen, Denmark. OPEN Health experts will contribute to the event through workshops, panel discussions, and 24 posters. Key themes of OPEN Healths research presented this year are patient preference, advanced modeling methodologies, and HTA policy changes. The majority of OPEN Healths Scientific Office will be onsite to discuss the role of HEOR science in shaping policy, including Dr. Elisabeth Fenwick, Chief Scientific Officer; Professor Ben van Hout, Scientific Founder; Dr. Marco Boeri, Director of Preference Research and scientific lead for Patient-Centered Outcomes; Emanuele Arc\u00e0, MSc, Senior Research Consultant in Strategic Market Access; and Maarten Treur, MSc, Vice President and Global Head of Modeling &amp; Meta-Analysis.<\/p>\n<p><strong>Dr. Elisabeth Fenwick, Chief Scientific Officer at OPEN Health, said<\/strong>: I am extremely proud to see the research we do at OPEN Health being presented by our scientific experts at the ISPOR EU conference in Copenhagen. The range of research topics covered this year shows the extent of our expertise in advanced techniques as well as key therapeutic areas.<\/p>\n<p><strong>Dr. Marco Boeri, Director of Preference Research and scientific lead for Patient-Centered Outcomes at OPEN Health, said:<\/strong>\u00a0The importance of patient preference information is that it brings a systematic approach to implement the idea of patient-focused drug development promoted by the FDA, the EMA, and various HTA bodies around the world. Indeed, the patient voice is key to patient adherence, and by helping to understand unmet needs, it is key to the success of a pharmaceutical product.<\/p>\n<p><strong>Emanuele Arc<\/strong><strong>\u00e0<\/strong><strong>, MSc, Senior Research Consultant in Strategic Market Access, said:<\/strong>\u00a0We are in a dynamic period of policy changes for access and HTA across regional, national, and international settings. HTA is taking a more prominent role in ensuring sustainable access to health innovations, while health innovations become exponentially more complex and expensive. We at OPEN Health are committed to understanding and shaping such changes through research and stakeholder engagement.<\/p>\n<p>OPEN Health will be presenting a virtual panel on November 10, ahead of ISPOR, on:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FYSPATGvXlAHP2rCAFwdS92AMGr1RQR9LLNrckShNZdQrAXyue8iHqFbBql2hGGMt5VxCqYRL7Sq59X8lWNmV2rQN6bMewwyGlgzooZjOhHTVFsp-Ljpsvt5zMsAlZ4_TPDJfMFp3Wh1T9oHOp08NUoUYSd9RBnYxAQVFQxLlQcn-i7O7DS8M5xj88Ee1qHJRhicbvz54h4fbDOznHnqef4CRTGx5LgMZ2EAsEYHb9_94OdO9jaVOILFkja9k4me-WIV2EUnYewlCW0cKwq6qjohBnXjuzdkL9IvkFujLyM-EgmmnpfAqsRKH_zJaO20JI-hmt0CfiuxBqwVMrEvqupdfaIaroEkbRzVbxRfpWg=\" rel=\"nofollow noopener\" target=\"_blank\"><strong>EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025.<\/strong><\/a>\u00a0The panel is set to discuss several policy aspects regarding the current challenges and implications of the EU HTA regulation, covering topics such as the current position of EU HTA implementation, the major challenges expected across the industry, the stance of member states and various stakeholders, and strategies for the industry to prepare for joint clinical assessments.\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IqgIhLYwCOlymBpAUxvZ7jMbSs04XgBnYKQplbYjoVN_IRS0Kd1Z8P_QcrIE4kAdLaguLJ26dmPgRTXKkgDwzYefzZ8Wypgt76ADe-eplGbZ67gQJ8xZI8TMJeOszDm-9zbeVw8O6bzU63mokCz6xQYOhrm_Z4qbGegiqHmJ0XTNPqUncsUjhWmZs7R0VmOB4wmSxeBC38oisRUV6ZXXXMi-HQHZ3lLjVIbq51AkWX8KAVk5TXip7eFqlblYbFtbFgAaPw0-1JXG87RZxYLKuQ==\" rel=\"nofollow noopener\" target=\"_blank\">Register now to save your seat.<\/a><\/p>\n<p>To learn more about our presence at ISPOR Europe,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DTRvR8GLVnlBH0Sdxj4DpAoZV3xcIikOlc7wRRtX8B82L9f2eCnKKejFc1wufwpzqFHMpTcRRKqc7eaiPwlxVnBKF_qHCdTu4JXtmoF4T8MBjDkXSoXy0NI7ehhuRZd2m49E_uxjGGWBPNtfzgDKOw==\" rel=\"nofollow noopener\" target=\"_blank\">visit our website<\/a> or meet the OPEN Health team at booth #C2-012 in Copenhagen.<\/p>\n<p \/>\n<b>About OPEN Health<\/b><\/p>\n<p>OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market access, scientific communications, patient engagement, and creative omnichannel communications. For more information on OPEN Health, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OTQ1Jth-3hXBPPH0K0IUhVuphKxhXVC3OKH5NX1BVzkb24wYmemea7KwOixXybmCHUHMp4Zt3QQrCO426z7Ky5RyEsmDqK4AcBhduUMsJvHyEKu868b9Lbz9TnuqgMfEQqUkN6R6OnKHrdGdPU3FCeQ_6SFDdx8VBX8k3Fsze2PQAEv3yL2zl2IZe7rS5b7j\" rel=\"nofollow noopener\" target=\"_blank\">www.openhealthgroup.com<\/a>.<\/p>\n<p \/>\n<b>Press contact:<\/b><\/p>\n<p><b>OPEN Health<\/b><\/p>\n<p>Candice Subero, Vice President, Global Marketing<\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iuK4M1eelZj0cUWIl0qS79dysFMnhQyErK6fdbrhq_-n-5ISSwLWbZE-588hWgPh_AZcB4zWbY1yb7yRV_XA9JaKnNYFZeJwSlRL5bGhCbhNlKi61Sq07YtC0Ubii3veTpepR-OR5bD5gdSNFwiD0w==\" rel=\"nofollow noopener\" target=\"_blank\">candicesubero@openhealthgroup.com<\/a><\/p>\n<p id=\"gnw_attachments_section-header\">\n <strong>Attachment<\/strong>\n<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n  <a target=\"_blank\" href=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/f6637df6-6bf0-42d1-81fe-9662239a4a5a\" rel=\"noopener\">OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe<\/a>\n<\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk3NjU5NiM1OTIxMDE2IzIwOTc2NDI=\" \/> <br \/><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NjY4ZWMwZjMtZDliNC00ZGY5LWJlZWItMGM3NmUxYjQ0MjkwLTExMDkyMTM=\/tiny\/Open-Health.png\" \/><\/p>\n<pre>Candice Subero\nOPEN Health\ncandicesubero@openhealthgroup.com\n<\/pre>\n<p>A <b>OESP<\/b> nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da <b>OESP<\/b> e sao de inteira responsabilidade da <b>GlobeNewswire<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"Open Health London, Nov. 09, 2023 (GLOBE NEWSWIRE) &#8212; London, UK November 9, 2023 \u00a0OPEN Health, a preeminent global provider of\u00a0consulting,\u00a0HEOR and market access,\u00a0patient engagement,","protected":false},"author":1,"featured_media":79069,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[34],"tags":[],"class_list":["post-79068","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-releases-geral"],"acf":[],"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/79068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=79068"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/79068\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media\/79069"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=79068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=79068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=79068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}